NovoCure (NVCR) Assets Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.91% |
| Dec 31, 2025 | -35.18% |
| Sep 30, 2025 | 11.39% |
| Jun 30, 2025 | 2.78% |
| Mar 31, 2025 | 11.36% |
| Dec 31, 2024 | 8.26% |
| Sep 30, 2024 | 6.60% |
| Jun 30, 2024 | 4.59% |
| Mar 31, 2024 | -4.51% |
| Dec 31, 2023 | -3.82% |
| Sep 30, 2023 | -2.37% |
| Jun 30, 2023 | -0.31% |
| Mar 31, 2023 | 2.10% |
| Dec 31, 2022 | 4.58% |
| Sep 30, 2022 | 4.80% |
| Jun 30, 2022 | 5.98% |
| Mar 31, 2022 | 7.73% |
| Dec 31, 2021 | 8.32% |
| Sep 30, 2021 | 159.94% |
| Jun 30, 2021 | 107.41% |
| Mar 31, 2021 | 112.49% |
| Dec 31, 2020 | 119.42% |
| Sep 30, 2020 | -2.89% |
| Jun 30, 2020 | 30.22% |
| Mar 31, 2020 | 35.70% |
| Dec 31, 2019 | 41.10% |
| Sep 30, 2019 | 40.68% |
| Jun 30, 2019 | 31.08% |
| Mar 31, 2019 | 22.00% |
| Dec 31, 2018 | 28.08% |
| Sep 30, 2018 | 20.30% |
| Jun 30, 2018 | 20.55% |
| Mar 31, 2018 | 14.68% |
| Dec 31, 2017 | -5.95% |
| Sep 30, 2017 | -9.90% |
| Jun 30, 2017 | 2.60% |
| Mar 31, 2017 | -5.16% |
| Dec 31, 2016 | -8.22% |
| Sep 30, 2016 | 67.51% |
| Dec 31, 2015 | 160.73% |